FDA Inspection 1100792 — Southwest Center for Reproductive Health PA
The FDA completed an inspection of Southwest Center for Reproductive Health PA on August 7, 2019 in El Paso, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 7, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- El Paso, TX (United States)